Roche Diagnostics Scandinavia AB has extended its co-operation agreement for Bullet kits, instruments and service by two years with NorDiag. The new agreement expires end April 2012. The agreement includes a minimum reagent purchase per year including fixed service contracts.
 
"Roche Diagnostics Scandinavia AB has an accumulated base of 7 Bullet instruments placed with customers in Sweden. These customers consume NorDiag sample preparation reagents on a routine basis and Roche has prolonged the agreement with NorDiag in order to secure supply of reagents", explains Mårten Wigstøl, CEO in NorDiag, and continues. "We appreciate this confirmation of our long standing relationship with Roche and the acceptance of the Bullet instrument among Roche's customers."
 
NorDiag's high/medium throughput instrument Bullet has the capacity of up to 100.000 isolations per year.
 
 
Contact:
CEO Mårten Wigstøl  -  Phone: +47 911 65775

Read the notice in Norwegian here.